Andersen Consulting udvider platformen med tilføjelsen af Liberty IT Consulting Group fra Australien
21.8.2025 18:12:00 CEST | Business Wire | Pressemeddelelse
Andersen Consulting styrker sine digitale transformationskompetencer yderligere med Liberty IT, der er en førende leverandør af digital transformation i virksomhedsklassen inden for finansielle services.
Liberty IT, der blev grundlagt i 2016 og har hovedkontor i Australien, specialiserer sig i teknologirådgivning for førende finansielle organisationer såsom banker, formueforvaltere og børsen. Virksomheden er specialiseret inden for modernisering af banksystemer, betalingsløsninger, data og digitale løsninger med særligt fokus på implementering af cloudbaserede løsninger, systemintegration, datamigrering, programmering, DevOps, kunstig intelligens og fusioner og integrationer af virksomheder. Med et stærkt renomme på markedet samarbejder Liberty IT med kunder om at levere skalerbare platforme, øge driftsmæssig effektivitet, optimere ydeevne, reducere omkostninger, maksimere sandsynligheden for succesfuld projektlevering og accelerere digitale transformationsinitiativer.
"Samarbejdet med Andersen Consulting gør det muligt for os at skalere vores påvirkning og tilføre endnu større værdi til kunder, der gennemgår teknologisk transformation – især inden for bank- og finanssektoren," siger John Dimitropoulos, der er CEO for Liberty IT. "Vores viden om branchen har, kombineret med et stærkt fokus på teknologi og en dyb forståelse for den australske kultur, gjort det muligt for os at bevare en konkurrencemæssig fordel på markedet. Sammen med Andersen Consultings globale ressourcer står vi stærkt rustet til at levere omfattende, effektive løsninger på globalt plan."
Mark L. Vorsatz, der er global formand og CEO for Andersen, tilføjede: "Liberty IT’s omdømme og fokus på langsigtet kundesucces stemmer overens med vores værdier. Dette samarbejde kommer til at styrke vores evne til at levere teknologidrevet transformation, så vi kan tilbyde vores kunder en integreret tilgang, der forener forretningsstrategi, indsigt i drift og avanceret teknisk implementering."
Andersen Consultinger en global konsulentvirksomhed, der tilbyder en omfattende portefølje af tjenester inden for virksomhedsstrategi, forretningsudvikling, teknologi og AI-transformation samt løsninger inden for humankapital. Andersen Consulting er integreret med den multidimensionelle servicemodel hos Andersen Global, der leverer brancheførende rådgivning inden for skat, jura, værdiansættelse, global mobilitet og øvrig rådgivning via en global platform med over 20.000 fagfolk verden over og tilstedeværelse på mere end 500 lokationer gennem sine medlemsfirmaer og samarbejdspartnere. Andersen Consulting Holdings LP er et kommanditselskab og tilbyder konsulentydelser gennem sine medlemsfirmaer og samarbejdspartnere over hele verden.
Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20250819346260/da/
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
RevolKa Reimagines Antibody Engineering with "RevoAb®"1.4.2026 06:30:00 CEST | Press release
A Same-day Sequence Optimization Service to Elevate Antibody Expression Levels by RevolKa’s advanced AI Protein Engineering Engine RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allo
Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 03:00:00 CEST | Press release
Online sales outpace in-store by 6x as digital-first and AI-influenced commerce accelerates globally NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales,
bet365 Partners with TestMu AI to Accelerate Global Release Velocity with Agentic AI Quality Engineering31.3.2026 19:01:00 CEST | Press release
Streamlines Hillside Technology testing across browsers and mobile devices while supporting rapid expansion into regulated markets. TestMu AI (Formerly LambdaTest), the world's first full-stack Agentic AI Quality Engineering platform, today announced that Hillside Technology Limited, the technology powerhouse behind global online gambling leader bet365, has adopted its platform to unify software testing and support hundreds of weekly production releases. The global online gaming industry is currently experiencing a massive shift, with the market projected to exceed $150 billion by 2030. As mobile gaming becomes the primary touchpoint for users, the technical complexity of delivering a seamless, low-latency experience has grown exponentially. For industry giants like bet365, the need to validate software across an infinite matrix of hardware, screen resolutions, and OS versions is a mission-critical requirement. This partnership ensures that, as gaming becomes more mobile-centric, bet36
IFF Secures First Heart Health Claim for Soy Protein in Australia and New Zealand31.3.2026 16:00:00 CEST | Press release
Regulatory milestone opens heart health growth opportunities for food and beverage manufacturers IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and health & biosciences announced today that a new heart health claim for isolated soy protein has been accepted by the Food Standards Australia New Zealand (FSANZ). The approval enables food and beverage manufacturers in Australia and New Zealand to link soy protein consumption with healthy blood cholesterol levels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330523416/en/ First heart health claim approved for soy protein in Australia and New Zealand. “For decades, IFF has invested in the science behind soy protein and its role in supporting cardiovascular health,” said Tony Andrew, vice president of protein solutions for IFF Food Ingredients. “This approved claim validates years of rigorous research and collaboration. With our deep expertise in ing
Sub-Q Bionics Closes $1.5M Pre-Seed Round to Advance Next-Generation Solution for Lymphedema Care31.3.2026 15:26:00 CEST | Press release
Sub-Q Bionics, a medical device company developing next-generation solutions to improve care for patients living with lymphedema, today announced the successful close of its $1.5 million pre-seed funding round. The round includes investment from Mayo Clinic and Yeda, the technology transfer company of the Weizmann Institute of Science, as well as several private investors. The Israel Innovation Authority also provided matching funds. The funding will enable Sub-Q Bionics to continue to develop its novel bionic lymph node technology designed to transform how lymphedema is managed, based on scientific innovations from the Weizmann Institute and Shamir Medical Center. The system aims to provide a solution to manage fluid with a subcutaneous implant that will allow patients freedom of movement, automatic fluid management and reduction of symptoms such as pain and swelling. Lymphedema affects millions of patients worldwide, especially breast cancer survivors, and remains significantly under
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum